Profound Medical (PROF) Non-Current Assets (2018 - 2026)
Profound Medical's (PROF) quarterly Non-Current Assets came in at $3.9 million in Q1 2026, up 312.39% year-on-year from $952000.0 in Q1 2025, and up 183.26% quarter-over-quarter from $1.4 million in Q4 2025.
Profound Medical (PROF) Non-Current Assets (2018 - 2026) Analysis & Trends
Profound Medical's Non-Current Assets history runs 9 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 312.39% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $7.0 million, a 5.66% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 18.56% from the prior year.
- Non-Current Assets advanced to $3.9 million in Q1 2026 per PROF's latest filing, from $1.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.9 million in Q1 2026 and bottomed at $781000.0 in Q3 2025.
- The 5-year median for Non-Current Assets is $1.3 million (2024), against an average of $1.7 million.
- Across the five-year window, Non-Current Assets tumbled 75.16% in 2022 and jumped 312.39% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $2.4 million in 2022, then decreased by 14.06% to $2.1 million in 2023, then tumbled by 43.25% to $1.2 million in 2024, then advanced by 18.56% to $1.4 million in 2025, then jumped by 183.26% to $3.9 million in 2026.
- Per Business Quant, the three latest PROF Non-Current Assets figures stand at $3.9 million (Q1 2026), $1.4 million (Q4 2025), and $781000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Profound Medical | 275.86 Mn | 225.57 Mn | 3.83 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 781,000.00 |
| Jun 30, 2025 | 857,000.00 |
| Mar 31, 2025 | 952,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Dec 31, 2021 | 9.65 Mn |
| Dec 31, 2020 | 6.86 Mn |
| Dec 31, 2019 | 7.14 Mn |
| Jan 1, 2019 | 6.33 Mn |
| Dec 31, 2018 | 6.54 Mn |